Cargando…

Nucleus-enriched Ruthenium Polypyridine Complex Acts as a Potent Inhibitor to Suppress Triple-negative Breast Cancer Metastasis In vivo

Polypyridine Ru(II) complexes have long been deemed to excellent antitumor agents that inhibit the proliferation of breast cancer cells. Nevertheless, their effects on the metastatic potency of breast cancer cells need further research. Herein, a class of polypyridine Ru(II) complexes coordinated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xuanhao, Li, Li, Yu, Gengnan, Zhang, Shuangyan, Li, Yumei, Wu, Qiong, Huang, Xiaoting, Mei, Wenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297906/
https://www.ncbi.nlm.nih.gov/pubmed/30581541
http://dx.doi.org/10.1016/j.csbj.2018.11.010
_version_ 1783381228586532864
author Zhao, Xuanhao
Li, Li
Yu, Gengnan
Zhang, Shuangyan
Li, Yumei
Wu, Qiong
Huang, Xiaoting
Mei, Wenjie
author_facet Zhao, Xuanhao
Li, Li
Yu, Gengnan
Zhang, Shuangyan
Li, Yumei
Wu, Qiong
Huang, Xiaoting
Mei, Wenjie
author_sort Zhao, Xuanhao
collection PubMed
description Polypyridine Ru(II) complexes have long been deemed to excellent antitumor agents that inhibit the proliferation of breast cancer cells. Nevertheless, their effects on the metastatic potency of breast cancer cells need further research. Herein, a class of polypyridine Ru(II) complexes coordinated with phenazine derivates (DPPZ) ([Ru(bpy)(2)(DPPZ-R)](ClO(4))(2), Ru(bpy)(2)DPPZ: R = -H, Ru(bpy)(2)BrDPPZ: R = -Br, Ru(bpy)(2)MDPPZ: R = -CH(3), Ru(bpy)2BnDPPZ: R = −acene, Ru(bpy)(2)BEDPPZ: R = -C ≡ C(C(6)H(5))) was synthesized by introducing different substituent groups to regulate the electron cloud density and planarity of the main ligands. Results indicated that this class of DPPZ-based Ru(II) complexes exhibited promising inhibitory effect against MDA-MB-231 triple-negative breast cancer cells, especially for Ru(bpy)(2)BEDPPZ, which is comparable with that of cisplatin. In addition, Ru(bpy)(2)BEDPPZ effectively inhibited the migration and invasion of MDA-MB-231 cells in vitro and suppressed focal adhesion and stress fiber formation. Moreover, it effectively blocked MDA-MB-231 cell metastasis in blood vessels and restrained angiogenesis formation in a zebrafish xenograft breast cancer model. Further studies showed that the mechanisms may involve DNA damage-mediated apoptosis probably due to Ru(bpy)(2)BEDPPZ, which was enriched in the cell nucleus and induced DNA damage. All these results suggested that the DPPZ-based Ru(II) complexes can act as potent anti-metastasis agents.
format Online
Article
Text
id pubmed-6297906
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Research Network of Computational and Structural Biotechnology
record_format MEDLINE/PubMed
spelling pubmed-62979062018-12-21 Nucleus-enriched Ruthenium Polypyridine Complex Acts as a Potent Inhibitor to Suppress Triple-negative Breast Cancer Metastasis In vivo Zhao, Xuanhao Li, Li Yu, Gengnan Zhang, Shuangyan Li, Yumei Wu, Qiong Huang, Xiaoting Mei, Wenjie Comput Struct Biotechnol J Research Article Polypyridine Ru(II) complexes have long been deemed to excellent antitumor agents that inhibit the proliferation of breast cancer cells. Nevertheless, their effects on the metastatic potency of breast cancer cells need further research. Herein, a class of polypyridine Ru(II) complexes coordinated with phenazine derivates (DPPZ) ([Ru(bpy)(2)(DPPZ-R)](ClO(4))(2), Ru(bpy)(2)DPPZ: R = -H, Ru(bpy)(2)BrDPPZ: R = -Br, Ru(bpy)(2)MDPPZ: R = -CH(3), Ru(bpy)2BnDPPZ: R = −acene, Ru(bpy)(2)BEDPPZ: R = -C ≡ C(C(6)H(5))) was synthesized by introducing different substituent groups to regulate the electron cloud density and planarity of the main ligands. Results indicated that this class of DPPZ-based Ru(II) complexes exhibited promising inhibitory effect against MDA-MB-231 triple-negative breast cancer cells, especially for Ru(bpy)(2)BEDPPZ, which is comparable with that of cisplatin. In addition, Ru(bpy)(2)BEDPPZ effectively inhibited the migration and invasion of MDA-MB-231 cells in vitro and suppressed focal adhesion and stress fiber formation. Moreover, it effectively blocked MDA-MB-231 cell metastasis in blood vessels and restrained angiogenesis formation in a zebrafish xenograft breast cancer model. Further studies showed that the mechanisms may involve DNA damage-mediated apoptosis probably due to Ru(bpy)(2)BEDPPZ, which was enriched in the cell nucleus and induced DNA damage. All these results suggested that the DPPZ-based Ru(II) complexes can act as potent anti-metastasis agents. Research Network of Computational and Structural Biotechnology 2018-11-29 /pmc/articles/PMC6297906/ /pubmed/30581541 http://dx.doi.org/10.1016/j.csbj.2018.11.010 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Zhao, Xuanhao
Li, Li
Yu, Gengnan
Zhang, Shuangyan
Li, Yumei
Wu, Qiong
Huang, Xiaoting
Mei, Wenjie
Nucleus-enriched Ruthenium Polypyridine Complex Acts as a Potent Inhibitor to Suppress Triple-negative Breast Cancer Metastasis In vivo
title Nucleus-enriched Ruthenium Polypyridine Complex Acts as a Potent Inhibitor to Suppress Triple-negative Breast Cancer Metastasis In vivo
title_full Nucleus-enriched Ruthenium Polypyridine Complex Acts as a Potent Inhibitor to Suppress Triple-negative Breast Cancer Metastasis In vivo
title_fullStr Nucleus-enriched Ruthenium Polypyridine Complex Acts as a Potent Inhibitor to Suppress Triple-negative Breast Cancer Metastasis In vivo
title_full_unstemmed Nucleus-enriched Ruthenium Polypyridine Complex Acts as a Potent Inhibitor to Suppress Triple-negative Breast Cancer Metastasis In vivo
title_short Nucleus-enriched Ruthenium Polypyridine Complex Acts as a Potent Inhibitor to Suppress Triple-negative Breast Cancer Metastasis In vivo
title_sort nucleus-enriched ruthenium polypyridine complex acts as a potent inhibitor to suppress triple-negative breast cancer metastasis in vivo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297906/
https://www.ncbi.nlm.nih.gov/pubmed/30581541
http://dx.doi.org/10.1016/j.csbj.2018.11.010
work_keys_str_mv AT zhaoxuanhao nucleusenrichedrutheniumpolypyridinecomplexactsasapotentinhibitortosuppresstriplenegativebreastcancermetastasisinvivo
AT lili nucleusenrichedrutheniumpolypyridinecomplexactsasapotentinhibitortosuppresstriplenegativebreastcancermetastasisinvivo
AT yugengnan nucleusenrichedrutheniumpolypyridinecomplexactsasapotentinhibitortosuppresstriplenegativebreastcancermetastasisinvivo
AT zhangshuangyan nucleusenrichedrutheniumpolypyridinecomplexactsasapotentinhibitortosuppresstriplenegativebreastcancermetastasisinvivo
AT liyumei nucleusenrichedrutheniumpolypyridinecomplexactsasapotentinhibitortosuppresstriplenegativebreastcancermetastasisinvivo
AT wuqiong nucleusenrichedrutheniumpolypyridinecomplexactsasapotentinhibitortosuppresstriplenegativebreastcancermetastasisinvivo
AT huangxiaoting nucleusenrichedrutheniumpolypyridinecomplexactsasapotentinhibitortosuppresstriplenegativebreastcancermetastasisinvivo
AT meiwenjie nucleusenrichedrutheniumpolypyridinecomplexactsasapotentinhibitortosuppresstriplenegativebreastcancermetastasisinvivo